2 assets in IDH-Wildtype Anaplastic Astrocytoma

Therapeutic assets addressing IDH-Wildtype Anaplastic Astrocytoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Icapamespib IDH-Wildtype Anaplastic Astrocytoma	Samus Therapeutics, Inc.	P1	CC (43)
wsd0922-fu IDH-Wildtype Anaplastic Astrocytoma	Mayo Clinic	P1	NR ()